Supportive Care in Cancer

, Volume 16, Issue 3, pp 275–283 | Cite as

Self-reported taste and smell changes during cancer chemotherapy

  • Britt-Marie Bernhardson
  • Carol Tishelman
  • Lars E. Rutqvist
Original Article



This study explores the prevalence of self-reported taste and smell changes (TSCs) during chemotherapy and relationships between TSCs and demographic and clinical factors.

Materials and methods

Consecutive patients who had received chemotherapy for ≥6 weeks at 11 outpatient chemotherapy units completed a questionnaire developed for this survey.


Seventy-five percent of the 518 participants reported TSCs, with TSCs more prevalent among women and younger patients. After adjustment for age and sex, we found that patients reporting TSCs more often reported: previous smell changes, less responsibility for cooking, concurrent medication, higher educational levels, and being on sick leave. Participants reporting oral problems, nausea, appetite loss, and depressed mood more frequently reported TSCs. Diagnosis and type of chemotherapy regimen did not predict TSCs.


TSCs were found to be common during cancer chemotherapy and were related to sociodemographic rather than clinical factors. TSCs were also found to be closely related to many other side effects of chemotherapy.


Antineoplastic agents Olfaction Taste Signs and symptoms Survey 



We thank the following agencies for economic support: the Swedish Health Care Sciences Postgraduate School, Karolinska Institutet (BMB), the Swedish Research Council (CT), and the Cancer & Traffic Injury Fund (project support). The authors also thank statisticians Hemming Johansson and Sara Runesdotter for their advice and support.


  1. 1.
    Bartoshuk LM (1990) Chemosensory alterations and cancer therapies. NCI Monogr 9:179–184PubMedGoogle Scholar
  2. 2.
    Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage (in press).Google Scholar
  3. 3.
    Berteretche MV, Dalix AM, d’Ornano AM, Bellisle F, Khayat D, Faurion A (2004) Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 12(8):571–576PubMedCrossRefGoogle Scholar
  4. 4.
    Bramerson A, Johansson L, Ek L, Nordin S, Bende M (2004) Prevalence of olfactory dysfunction: the skovde population-based study. Laryngoscope 114(4):733–737PubMedCrossRefGoogle Scholar
  5. 5.
    Cameron B, Quested Evans (2003) A matter of taste: the experience of chemotherapy related taste changes. Aust J Cancer Nursing 4(1):3–9Google Scholar
  6. 6.
    Carelle NPE, Bellanger A, Germanaud J, Thuillier A, Khayat D (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95(1):155–163PubMedCrossRefGoogle Scholar
  7. 7.
    Collins D (2003) Pretesting survey instruments: an overview of cognitive methods. Qual Life Res 12(3):229–238PubMedCrossRefGoogle Scholar
  8. 8.
    Doty RL, Bromley SM (2004) Effects of drugs on olfaction and taste. Otolaryngol Clin North Am 37(6):1229–1254PubMedCrossRefGoogle Scholar
  9. 9.
    Duffy V, Fast K, Lucchina L, Bartoshuk L (2002) Oral sensation and cancer. In: Berger A, Portenoy R, Weissman D (eds) Principles and practice of palliative care and supportive oncology. Lippincott Williams and Wilkins, Philadelphia, pp 178–193Google Scholar
  10. 10.
    Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30(11):785–792PubMedCrossRefGoogle Scholar
  11. 11.
    Foltz AT, Gaines G, Gullatte M (1996) Recalled side effects and self-care actions of patients receiving inpatient chemotherapy. Oncol Nurs Forum 23(4):679–683PubMedGoogle Scholar
  12. 12.
    Frasnelli JTH (2004) Olfactory dysfunction and daily life. Eur Arch Oto-Rhino-Laryngol Hand Neck 265(3):231–235Google Scholar
  13. 13.
    Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7(2):189–195PubMedGoogle Scholar
  14. 14.
    Higgins SC, Montgomery GH, Bovbjerg DH (2007) Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer 15:171–177PubMedCrossRefGoogle Scholar
  15. 15.
    Jobe JB, Mingay DJ (1989) Cognitive research improves questionnaires. Am J Public Health 79(8):1053–1055PubMedGoogle Scholar
  16. 16.
    Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61(2):162–175PubMedCrossRefGoogle Scholar
  17. 17.
    Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282 (quiz 283–4)PubMedCrossRefGoogle Scholar
  18. 18.
    Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, Adkins S, Sawyer WT (1999) Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 7(2):59–65PubMedCrossRefGoogle Scholar
  19. 19.
    Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringden O (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21(1):33–37PubMedCrossRefGoogle Scholar
  20. 20.
    Miller M, Kearney N (2004) Chemotherapy-related nausea and vomiting-past reflections, present practice and future management. Eur J Cancer Care (Engl) 13(1):71–81CrossRefGoogle Scholar
  21. 21.
    Mulder NH, Smit JM, Kreumer WM, Bouman J, Sleijfer DT, Veeger W, Schraffordt Koops H (1983) Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma. Oncology 40(1):36–38PubMedCrossRefGoogle Scholar
  22. 22.
    Nail LM, Jones LS, Greene D, Schipper DL, Jensen R (1991) Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum 18(5):883–887PubMedGoogle Scholar
  23. 23.
    Nordin S, Bramerson A, Murphy C, Bende M (2003) A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire: evaluation of questions about olfaction. Acta Otolaryngol 123(4):536–542PubMedCrossRefGoogle Scholar
  24. 24.
    Olofsson JK, Nordin S (2004) Gender differences in chemosensory perception and event-related potentials. Chem Senses 29(7):629–637PubMedCrossRefGoogle Scholar
  25. 25.
    Rhodes VA, McDaniel RW, Hanson B, Markway E, Johnson M (1994) Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nurs 17(1):45–51PubMedCrossRefGoogle Scholar
  26. 26.
    Schiffman SS (1997) Taste and smell losses in normal aging and disease. Jama 278(16):1357–1362PubMedCrossRefGoogle Scholar
  27. 27.
    Schiffman SS, Gatlin CA (1993) Clinical physiology of taste and smell. Annu Rev Nutr 13:405–436PubMedCrossRefGoogle Scholar
  28. 28.
    Sherry VW (2002) Taste alterations among patients with cancer. Clin J Oncol Nurs 6(2):73–77PubMedCrossRefGoogle Scholar
  29. 29.
    Sitzia J, North C, Stanley J, Winterberg N (1997) Side effects of CHOP in the treatment of non-Hodgkin’s lymphoma. Cancer Nurs 20(6):430–439PubMedCrossRefGoogle Scholar
  30. 30.
    Thorne S, Kirkham S, MacDonald-Emes J (1997) Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health 20:169–177PubMedCrossRefGoogle Scholar
  31. 31.
    Thorne S, O’Flynn-Magee K (2004) The analytic challenge in interpretive description. Int J Qual Methods 3(1):1–21Google Scholar
  32. 32.
    Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, Potter C, Blendowski C (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26(4):697–706PubMedGoogle Scholar
  33. 33.
    Youngblood M, Williams PD, Eyles H, Waring J, Runyon S (1994) A comparison of two methods of assessing cancer therapy-related symptoms. Cancer Nurs 17(1):37–44PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Britt-Marie Bernhardson
    • 1
    • 2
  • Carol Tishelman
    • 1
    • 2
    • 3
  • Lars E. Rutqvist
    • 4
  1. 1.Department NVS, Division of NursingKarolinska InstitutetStockholmSweden
  2. 2.R&D UnitStockholms Sjukhem FoundationStockholmSweden
  3. 3.Department of Medical Epidemiology and BiostatisticsKarolinska InstitutetStockholmSweden
  4. 4.Department of Oncology and PathologyKarolinska InstitutetStockholmSweden

Personalised recommendations